PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

ethosuximide

Verify with FDA → · CMS NADAC pricing →

Brand names: Zarontin

Anticonvulsant (Succinimide) Rx

Ethosuximide is a medicine that helps control absence seizures. It belongs to a class of drugs called anticonvulsants.

Drug Pricing (NADAC)

Generic Price

$0.23/unit

Generic Available

Yes (6 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Ethosuximide is used to control absence seizures, also known as petit mal epilepsy.

Common side effects

Loss of appetite, Upset stomach, Nausea

Key warnings

Ethosuximide can cause serious blood problems.

How It Works

Ethosuximide works by reducing unusual electrical activity in the brain. This helps to prevent absence seizures. The exact way it does this is not completely understood.

How to Take It

Take ethosuximide capsules by mouth. If you are 3 to 6 years old, you will usually start with one 250 mg capsule daily. If you are 6 years or older, you will usually start with two 250 mg capsules (500 mg total) daily. Your doctor may change your dose every 4 to 7 days to best control your seizures. Follow your doctor's instructions carefully.

Pregnancy & Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if ethosuximide will harm your unborn baby. Talk to your doctor about the risks and benefits of taking this medicine during pregnancy and breastfeeding.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Storage

Store ethosuximide capsules at room temperature, away from heat and moisture.

Side Effects (from patient reports)

Based on 1,914 FDA adverse event reports.

Medicine not working
498
Seizure
347
Using the medicine for something it's not approved for
225
Drowsiness
146
Grand mal seizure
140
Absence seizure
117
Treatment not working
114
Medicine interacting with another medicine
113
Tiredness
109
Epilepsy
105

FDA Adverse Event Report Analysis

Detailed analysis of 2,415 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

2,415

Death-Related Reports

62

Hospitalization Reports

568

Top Indication

Epilepsy

Gender Distribution

Female 1,173 (58%)
Male 846 (42%)

Age Distribution

0–17 969
18–44 417
45–64 131
65–74 40
75+ 28

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DRUG INEFFECTIVE 498
2 SEIZURE 347
3 OFF LABEL USE 225
4 SOMNOLENCE 146
5 GENERALISED TONIC-CLONIC SEIZURE 140
6 PETIT MAL EPILEPSY 117
7 TREATMENT FAILURE 114
8 DRUG INTERACTION 113
9 FATIGUE 109
10 EPILEPSY 105
11 MULTIPLE-DRUG RESISTANCE 101
12 CONDITION AGGRAVATED 99
13 VOMITING 95
14 STATUS EPILEPTICUS 89
15 DECREASED APPETITE 81

Reactions in Death Reports

SEIZURE 13
OFF LABEL USE 11
DEATH 10
SOMNOLENCE 10
ABNORMAL WEIGHT GAIN 9
COLON CANCER 9
DYSKINESIA 9
DYSPNOEA 9
FEELING HOT 9
GYNAECOMASTIA 9

Reactions in Hospitalization Reports

SEIZURE 92
DRUG INEFFECTIVE 84
OFF LABEL USE 54
DRUG INTERACTION 39
SOMNOLENCE 38
VOMITING 38
EPILEPSY 32
GENERALISED TONIC-CLONIC SEIZURE 31
STATUS EPILEPTICUS 29
PETIT MAL EPILEPSY 28

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Ethosuximide can cause serious blood problems. Tell your doctor right away if you have a fever, sore throat, or unusual bleeding or bruising. Rarely, this medicine can cause severe allergic reactions or liver problems.

Known Drug Interactions

In addition, carbamazepine causes, or would be expected to cause, decreased levels of the following drugs, for which monitoring of concentrations or dosage adjustment may be necessary: acetaminophen, albendazole, alprazolam, aprepitant, buprenorphone, bupropion, citalopram, clonazepam, clozapine, corticosteroids (e.g., prednisolone, dexamethasone), cyclosporine, dicumarol, dihydropyridine calcium channel blockers (e.g., felodipine), doxycycline, ethosuximide, everolimus, haloperidol, imatinib, itraconazole, lamotrigine, levothyroxine, methadone, methsuximide, mianserin, midazolam, olanzapin...

Mechanism: Carbamazepine causes your body to process and remove ethosuximide faster than usual, leading to lower levels of the drug in your system.

What to do: Your doctor may need to monitor your blood levels or adjust your dose of ethosuximide.

Table 1: Drugs That Affect Phenytoin Concentrations Interacting Agent Examples Drugs that may increase phenytoin serum levels Antiepileptic drugs Ethosuximide, felbamate, oxcarbazepine, methsuximide, topiramate Azoles Fluconazole, ketoconazole, itraconazole, miconazole, voriconazole Antineoplastic agents Capecitabine, fluorouracil Antidepressants Fluoxetine, fluvoxamine, sertraline Gastric acid reducing agents H 2 antagonists (cimetidine), omeprazole Sulfonamides Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole trimethoprim Other Acute alcohol intake, amiodarone, chloramphenic...

Mechanism: Ethosuximide can slow down the breakdown of phenytoin in your body, which may lead to higher levels of phenytoin in your blood.

What to do: Your doctor may need to check your blood levels and lower your phenytoin dose to avoid side effects.

diazepam, ethosuximide, lamotrigine, phenytoin) by inhibiting their metabolism or protein binding displacement ( 7.2 ) • Patients stabilized on rufinamide should begin valproate therapy at a low dose, and titrate to clinically effective dose ( 7.2 ) • Dosage adjustment of amitriptyline/nortriptyline, propofol, warfarin, and zidovudine may be necessary if used concomitantly with valproate ( 7.2 ) • Topiramate: Hyperammonemia and encephalopathy ( 5.9 , 7.3 ) 7.1 Effects of Co-Administered Drugs on Valproate Clearance Drugs that affect the level of expression of hepatic enzymes, particularly t...

Mechanism: Valproate can slow down how your body breaks down ethosuximide or change how it travels in your blood. This can cause the level of ethosuximide in your body to rise.

What to do: Your doctor may need to adjust your ethosuximide dose and watch for any new side effects.

Common Questions

Can I take ethosuximide with other seizure medicines?
Yes, ethosuximide may be taken with other seizure medicines if needed.
Will ethosuximide cure my epilepsy?
Ethosuximide helps control seizures, but it is not a cure for epilepsy.
How long will I need to take ethosuximide?
You may need to take ethosuximide for a long time to control your seizures. Talk to your doctor before stopping.
Can ethosuximide affect my mood?
Yes, ethosuximide can sometimes cause mood changes, such as irritability or aggressiveness.
What should I do if I have side effects?
Tell your doctor if you have any side effects that bother you or do not go away.
Can I drink alcohol while taking ethosuximide?
Talk to your doctor about drinking alcohol while taking ethosuximide. Alcohol can make some side effects worse.
Does ethosuximide interact with other medicines?
Yes, ethosuximide can interact with some other medicines. Tell your doctor about all the medicines you take.
Will ethosuximide affect my ability to drive?
Ethosuximide can cause drowsiness or dizziness, which can affect your ability to drive. Do not drive until you know how this medicine affects you.
How often will I see my doctor while taking ethosuximide?
Your doctor will want to see you regularly to check your progress and monitor for side effects.
What do the capsules look like?
Ethosuximide capsules are clear orange-colored, oblong-shaped, soft gelatin capsules, imprinted "HP 532" with white ink.
What are the common side effects of ethosuximide?
The most commonly reported side effects of ethosuximide include Loss of appetite, Upset stomach, Nausea, Vomiting, Cramps. Based on 1,914 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does ethosuximide interact with other medications?
Yes, ethosuximide has 3 known drug interactions. Notable interactions include carbamazepine, phenytoin, valproate. Always inform your doctor about all medications you are taking.
What drug class is ethosuximide?
ethosuximide belongs to the Anticonvulsant (Succinimide) drug class. It requires a prescription (Rx). Ethosuximide is used to control absence seizures, also known as petit mal epilepsy.
Is ethosuximide safe during pregnancy?
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if ethosuximide will harm your unborn baby. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Anticonvulsant (Succinimide)

Other drugs grouped near ethosuximide — same-class peers and common alternatives.

Compare ethosuximide vs brivaracetam side-by-side →

Medication Guides

Related Health & Safety Data

Save on ethosuximide

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for ethosuximide

The FDA label for ethosuximide (sold under brand names such as Zarontin) classifies it as a prescription-only medication in the Anticonvulsant (Succinimide) class. Ethosuximide is used to control absence seizures, also known as petit mal epilepsy. Official labeling lists 18 commonly reported side effects, including Loss of appetite, Upset stomach, Nausea.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 1,914 voluntary reports. The database also lists 3 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $0.23.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: December 23, 2021

All federal data sources used on this page